Elanco Animal Health Inc

For the period ended Jun 30, 2026. Filed Aug 5, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 5, 2026

ELAN$26.76-0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 2. RESULTS OF OPERATIONS

Results of Operations

The following discussion and analysis of our results of operations should be read along with our condensed consolidated financial statements and the notes thereto. Our results of operations for the periods presented below may not be comparable with prior periods or with our results of operations in the future due to many factors, including but not limited to the factors identified above.

	Three Months Ended June 30,			Six Months Ended June 30,
(Dollars in millions)	2026	2025	% Change	2026	2025	% Change
Revenue	$1,368	$1,241	10%	$2,739	$2,434	13%
Cost of sales	570	528	8%	1,156	1,037	11%
Gross profit	798	713	12%	1,583	1,397	13%
Research and development	92	92	—%	189	186	2%
Marketing, selling and administrative	449	400	12%	830	741	12%
Amortization of intangible assets	139	136	2%	277	264	5%
Asset impairment, restructuring and other special charges	9	1	NM	25	10	150%
Interest expense, net of capitalized interest	59	48	23%	116	88	32%
Other (income) expense, net	(6)	11	NM	3	23	NM
Income before income taxes	56	25	124%	143	85	68%
Income tax expense	2	14	NM	32	7	NM
Net income	$54	$11	391%	$111	$78	42%

Certain amounts and percentages may reflect rounding adjustments.

NM - Not meaningful

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.